Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Phospholamban Antikörper (N-Term)

Dieses Anti-Phospholamban-Antikörper ist ein Kaninchen Polyklonal-Antikörper zur Detektion von Phospholamban in WB. Geeignet für Human. Dieses Primary Antibody wurde in 4+ Publikationen zitiert.
Produktnummer ABIN1882182

Kurzübersicht für Phospholamban Antikörper (N-Term) (ABIN1882182)

Target

Alle Phospholamban (PLN) Antikörper anzeigen
Phospholamban (PLN)

Reaktivität

  • 86
  • 24
  • 22
  • 3
  • 2
  • 2
  • 2
Human

Wirt

  • 87
  • 3
  • 1
Kaninchen

Klonalität

  • 86
  • 5
Polyklonal

Konjugat

  • 44
  • 6
  • 5
  • 5
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
Dieser Phospholamban Antikörper ist unkonjugiert

Applikation

  • 37
  • 35
  • 26
  • 26
  • 22
  • 11
  • 10
  • 9
  • 9
  • 9
  • 7
  • 6
  • 1
  • 1
Western Blotting (WB)

Klon

RB44799
  • Bindungsspezifität

    • 26
    • 17
    • 12
    • 9
    • 8
    • 7
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 1-22, N-Term

    Homologie

    B, M, Pig, Rb, Rat

    Aufreinigung

    This antibody is purified through a protein A column, followed by peptide affinity purification.

    Immunogen

    This PLN antibody is generated from a rabbit immunized with a KLH conjugated synthetic peptide between 1-22 amino acids from the N-terminal region of human PLN.

    Isotyp

    Ig Fraction
  • Applikationshinweise

    WB: 1:1000

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Buffer

    Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    4 °C,-20 °C

    Haltbarkeit

    6 months
  • Kaliman, Catalucci, Lam, Kondo, Gutiérrez, Reddy, Palacín, Zorzano, Chien, Ruiz-Lozano: "Myotonic dystrophy protein kinase phosphorylates phospholamban and regulates calcium uptake in cardiomyocyte sarcoplasmic reticulum." in: The Journal of biological chemistry, Vol. 280, Issue 9, pp. 8016-21, (2005) (PubMed).

    Minamisawa, Sato, Tatsuguchi, Fujino, Imamura, Uetsuka, Nakazawa, Matsuoka: "Mutation of the phospholamban promoter associated with hypertrophic cardiomyopathy." in: Biochemical and biophysical research communications, Vol. 304, Issue 1, pp. 1-4, (2003) (PubMed).

    McTiernan, Frye, Lemster, Kinder, Ogletree-Hughes, Moravec, Feldman: "The human phospholamban gene: structure and expression." in: Journal of molecular and cellular cardiology, Vol. 31, Issue 3, pp. 679-92, (1999) (PubMed).

    Fujii, Zarain-Herzberg, Willard, Tada, MacLennan: "Structure of the rabbit phospholamban gene, cloning of the human cDNA, and assignment of the gene to human chromosome 6." in: The Journal of biological chemistry, Vol. 266, Issue 18, pp. 11669-75, (1991) (PubMed).

  • Target

    Phospholamban (PLN)

    Andere Bezeichnung

    PLN

    Hintergrund

    Reversibly inhibits the activity of ATP2A2 in cardiac sarcoplasmic reticulum by decreasing the apparent affinity of the ATPase for Ca(2+). Modulates the contractility of the heart muscle in response to physiological stimuli via its effects on ATP2A2 Modulates calcium re-uptake during muscle relaxation and plays an important role in calcium homeostasis in the heart muscle. The degree of ATP2A2 inhibition depends on the oligomeric state of PLN. ATP2A2 inhibition is alleviated by PLN phosphorylation.

    Molekulargewicht

    6109

    UniProt

    P26678

    Pathways

    Negative Regulation of Transporter Activity
Sie sind hier:
Chat with us!